Global Transcatheter Aortic Valve Replacement (TAVR) In-Depth Industrial and Market studies: Industry Analysis & Outlook (2017-2021)
 |
| Transcatheter Aortic Valve Replacement (TAVR) |
Albany, New York, Mar 07, 2017
"Global
Transcatheter Aortic Valve Replacement (TAVR) Market: Industry
Analysis & Outlook (2017-2021)"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Transcatheter
aortic valve replacement (TAVR) is a relatively new technology in the
field of medical science. It is a less intrusive method of replacing
heart valve without undergoing the conventional by-pass surgery. Due
to the less invasive nature of the surgery, it has emerged as the
more feasible alternative to conventional surgical aortic valve
replacement. Transcatheter aortic valve replacement is sometimes
called as Transcatheter aortic valve implantation (TAVI).
TAVR
may be an option for people who are considered at intermediate or
high risk of complications from surgical aortic valve replacement. It
may also be suggested in certain cases where patient cannot undergo
open-heart surgery. The decision to treat aortic stenosis with TAVR
is made after consultation with a multidisciplinary group of medical
and surgical heart specialists who together determine the best
treatment option for each individual.
The
global TAVR market is set to experience favourable growth driven by
factors such as increasing elderly population, rising health care
expenditure, increasing obese population and global economic
development. Further, the scope of growth for this market will be
broadened by increasing prevalence of aortic stenosis amongst the
patients and rising demand for minimally invasive procedures.
However, the growth of this budding market will be hindered by the
business cycle fluctuations and risk of security breaches such as
stringent regulations, high cost of TAVR devices and high risks
associated with the TAVR procedure.
The report “Global TAVR Market: Industry
Analysis & Outlook (2017-2021)” analyses the development of
this market, with focus on the U.S, Asia Pacific and European
markets. The major trends, growth drivers as well as issues being
faced by the market are discussed in detail in this report. The four
major players: Edwards Lifesciences, Boston Scientific, Medtronic
Plc. and St. Jude Medical, Inc. are being profiled along with their
key financials and strategies for growth. The report contains a
comprehensive analysis of the global TAVR market along with the study
of the regional markets.
– Table of Content
1. Introduction
1.1 TAVR Overview
2. Global Market Analysis
2.1 Global TAVR Market by Value
2.2 Global TAVR Market Forecast by Value
2.3 Global TAVR Implant Volume
2.4 Global TAVR Implant Volume Forecast
2.5 Global TAVR Patient Population
2.6 Global TAVR Patient Population Forecast
3. Regional Market Analysis
3.1 The U.S.
3.1.1 The U.S. TAVR Market by Value
3.1.2 The U.S TAVR Forecast by Value
3.1.3 The U.S. TAVR Implant Volume
3.1.4 The U.S. TAVR Implant Volume Forecast
3.1.5 The U.S. TAVR Implant Volume by Patient Type
3.1.6 The U.S. TAVR Implant Volume Forecast-Patient Type
3.1.7 The U.S. TAVR Implant Volume by Access Route
3.1.8 The U.S. Aortic Valve Disease Patient Population Forecast
3.2 Outside the U.S.
3.2.1 OUS TAVR Market by Value
3.2.2 OUS TAVR Market Forecast by Value
3.2.3 OUS TAVR Implant Volume
3.2.4 OUS TAVR Implant Forecast by Volume
3.2.5 OUS TAVR Patient Population
3.2.6 OUS TAVR Patient Population Forecast
3.2.7 Europe TAVR Implant Volume by Patient Type
3.2.8 Europe TAVR Implant Volume Forecast by Patient Type
3.2.9 Europe TAVR Implant Volume by Access Route
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Aging Population
4.1.2 Rising HealthCare Expenditure
4.1.3 Increasing Obese Population
4.1.4 Economic Development
4.1.5 Increasing Prevalence of Inoperable Aortic Stenosis
4.2 Key Trends & Development
4.2.1 Recent Technological Advancements
4.2.2 Favourable Reimbursement Policies in Europe
4.3 Challenges
4.3.1 Stringent Regulations
4.3.2 High Cost of TAVR Devices
4.3.3 Associated High Risk
5. Competition
5.1 Global Market
5.1.1 Global TAVR Market Share by Company
5.1.2 Global TAVR Market-Implanting Centres by Company
5.1.3 Global TAVR Market-Total Implants by Company
5.1.4 Global TAVR Market-Average Selling Price of Implants by Company
5.2 The U.S.
5.2.1 The U.S. TAVR Market Share by Company
5.2.2 The U.S. TAVR Market-Implanting Centres by Company
5.2.3 The U.S. TAVR Market-Total Implants by Company
1.1 TAVR Overview
2. Global Market Analysis
2.1 Global TAVR Market by Value
2.2 Global TAVR Market Forecast by Value
2.3 Global TAVR Implant Volume
2.4 Global TAVR Implant Volume Forecast
2.5 Global TAVR Patient Population
2.6 Global TAVR Patient Population Forecast
3. Regional Market Analysis
3.1 The U.S.
3.1.1 The U.S. TAVR Market by Value
3.1.2 The U.S TAVR Forecast by Value
3.1.3 The U.S. TAVR Implant Volume
3.1.4 The U.S. TAVR Implant Volume Forecast
3.1.5 The U.S. TAVR Implant Volume by Patient Type
3.1.6 The U.S. TAVR Implant Volume Forecast-Patient Type
3.1.7 The U.S. TAVR Implant Volume by Access Route
3.1.8 The U.S. Aortic Valve Disease Patient Population Forecast
3.2 Outside the U.S.
3.2.1 OUS TAVR Market by Value
3.2.2 OUS TAVR Market Forecast by Value
3.2.3 OUS TAVR Implant Volume
3.2.4 OUS TAVR Implant Forecast by Volume
3.2.5 OUS TAVR Patient Population
3.2.6 OUS TAVR Patient Population Forecast
3.2.7 Europe TAVR Implant Volume by Patient Type
3.2.8 Europe TAVR Implant Volume Forecast by Patient Type
3.2.9 Europe TAVR Implant Volume by Access Route
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Aging Population
4.1.2 Rising HealthCare Expenditure
4.1.3 Increasing Obese Population
4.1.4 Economic Development
4.1.5 Increasing Prevalence of Inoperable Aortic Stenosis
4.2 Key Trends & Development
4.2.1 Recent Technological Advancements
4.2.2 Favourable Reimbursement Policies in Europe
4.3 Challenges
4.3.1 Stringent Regulations
4.3.2 High Cost of TAVR Devices
4.3.3 Associated High Risk
5. Competition
5.1 Global Market
5.1.1 Global TAVR Market Share by Company
5.1.2 Global TAVR Market-Implanting Centres by Company
5.1.3 Global TAVR Market-Total Implants by Company
5.1.4 Global TAVR Market-Average Selling Price of Implants by Company
5.2 The U.S.
5.2.1 The U.S. TAVR Market Share by Company
5.2.2 The U.S. TAVR Market-Implanting Centres by Company
5.2.3 The U.S. TAVR Market-Total Implants by Company
Comments
Post a Comment